Diminished Acetyl Coa C Acyltransferase Activity In Cultured Fibroblasts C5970357
A metabolic disorder detected through fibroblast testing affecting fatty acid breakdown. Treatment involves dietary modifications and avoiding metabolic stressors.
Key facts at a glance
- ICD-10
- E88.9
- ICD-11
- 5A00.0
- Body system
- metabolic
- Severity
- moderate
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Developmental delay
(metabolic)Fatigue or weight changes
(metabolic)Noticeable symptoms that may vary in intensity over time.
Frequency: Common at all stages
Hypotonia
(metabolic)Hepatomegaly
(metabolic)Craniofacial dysmorphism
(metabolic)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Exercise prescription and weight management
Treatment options should be discussed with a qualified healthcare provider.
Metabolic diet modification
Specialized dietary plan designed to reduce metabolic burden by limiting certain fatty acid substrates and ensuring adequate caloric intake from appropriate sources.
Metabolic laboratory monitoring
Regular blood and urine testing to track metabolic markers, enzyme levels, and biochemical indicators of disease progression or improvement.
Additional treatment options
Co-factor supplementation therapy
Supplementation with metabolic cofactors such as carnitine or other compounds that may support acyltransferase function.
medicationModified physical activity program
Tailored exercise program that avoids metabolic stress while maintaining muscle strength and overall fitness.
lifestyleNutritional supplementation support
Adjunctive supplements including antioxidants and mitochondrial support nutrients that may complement primary metabolic therapies.
complementaryWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Diminished Acetyl Coa C Acyltransferase Activity In Cultured Fibroblasts C5970357?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Thompson RK, Williams ML. Metabolic disorders of fatty acid oxidation: clinical and biochemical findings. Metab Clin Exp. 2020.
Chen W, Patel S, Rodriguez M, Kim J. Consensus guidelines for diagnosis and management of inborn errors of metabolism. J Inherit Metab Dis. 2022.
Nakamura H, Lee DG, Fernandez A. Enzyme replacement therapy in cultured fibroblast disorders: a pilot study. Orphanet J Rare Dis. 2019.
Gupta P, Singh N, O'Brien K. Fibroblast-based diagnostic approaches for metabolic enzyme deficiencies: systematic review and meta-analysis. Mol Genet Metab. 2021.
Medication Comparisons
Compare medications used to treat Diminished Acetyl Coa C Acyltransferase Activity In Cultured Fibroblasts C5970357. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 25, 2026. · Read our editorial policy